Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

DAY ONE BIOPHARMACEUTICALS, INC.

(DAWN)
  Report
Delayed Nasdaq  -  04:00 2022-12-02 pm EST
21.74 USD   +2.45%
12/01BofA Securities Starts Day One Biopharmaceuticals at Buy With $34 Price Target
MT
11/17Day One to Participate in the Piper Sandler 34th Annual Healthcare Conference
GL
11/17Day One to Participate in the Piper Sandler 34th Annual Healthcare Conference
GL
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/28/2022 11/29/2022 11/30/2022 12/01/2022 12/02/2022 Date
20.12(c) 20.35(c) 21.23(c) 21.22(c) 21.74(c) Last
349 088 553 214 385 085 436 870 461 844 Volume
-6.03% +1.14% +4.32% -0.05% +2.45% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 - - -
Net income 2022 -142 M - -
Net cash position 2022 120 M - -
P/E ratio 2022 -10,0x
Yield 2022 -
Sales 2023 1,51 M - -
Net income 2023 -174 M - -
Net cash position 2023 359 M - -
P/E ratio 2023 -9,64x
Yield 2023 -
Capitalization 1 599 M 1 599 M -
EV / Sales 2022 -
EV / Sales 2023 823x
Nbr of Employees 102
Free-Float 70,5%
More Financials
Company
Day One Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing targeted therapies for patients of all ages with genomically-defined cancers. It seeks to identify, acquires, and develops product candidates that target high-value oncogenic drivers in cancers with unmet need, with an initial focus on pediatric patients. Its lead product candidate, DAY101... 
More about the company
Ratings of Day One Biopharmaceuticals, Inc.
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
-
More Ratings
All news about DAY ONE BIOPHARMACEUTICALS, INC.
12/01BofA Securities Starts Day One Biopharmaceuticals at Buy With $34 Price Target
MT
11/17Day One to Participate in the Piper Sandler 34th Annual Healthcare Conference
GL
11/17Day One to Participate in the Piper Sandler 34th Annual Healthcare Conference
GL
11/11Day One Announces Upcoming Presentations at 2022 Society for Neuro-Oncology Annual Meet..
GL
11/11Day One Announces Upcoming Presentations at 2022 Society for Neuro-Oncology Annual Meet..
GL
11/08Day One Biopharmaceuticals Q3 Loss Widens
MT
11/07DAY ONE BIOPHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Con..
AQ
11/07Day One Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nin..
CI
11/07Day One Biopharmaceuticals, Inc. : Results of Operations and Financial Condition, Regulati..
AQ
11/07Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
GL
11/07Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
AQ
11/03Insider Sell: Day One Biopharmaceuticals
MT
10/17Day One Signs Cooperative Research, Development Deal With National Cancer Institute For..
MT
10/17Day One Announces Cooperative Research and Development Agreement with National Cancer I..
GL
10/17Day One Announces Cooperative Research and Development Agreement with National Cancer I..
AQ
More news
News in other languages on DAY ONE BIOPHARMACEUTICALS, INC.
11/08La perte de Day One Biopharmaceuticals au 3e trimestre s'accentue
11/07Day One Biopharmaceuticals, Inc. annonce ses résultats pour le troisième trimestre et l..
11/03Vente d'initiés : Day One Biopharmaceuticals
10/17Day One signe un accord de coopération en matière de recherche et de développement avec..
10/17Day One annonce un accord de coopération en recherche et développement avec le National..
More news
Analyst Recommendations on DAY ONE BIOPHARMACEUTICALS, INC.
More recommendations
ETFs positioned on DAY ONE BIOPHARMACEUTICALS, INC.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Virtus LifeSci Biotech Clinical Trials ETF - USD0.77%0.55%United_States
ALPS Medical Breakthroughs ETF - USD0.66%1.56%United_States
Invesco DWA SmallCap Momentum ETF - USD0.53%0.18%United_States
SPDR S&P Biotech ETF - USD0.46%2.58%United_States
ETFs S&P Biotech ETF - Distributing - AUD0.45%2.60%-United_States
More ETFs positioned on DAY ONE BIOPHARMACEUTICALS, INC.
Chart DAY ONE BIOPHARMACEUTICALS, INC.
Duration : Period :
Day One Biopharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DAY ONE BIOPHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 21,74 $
Average target price 36,25 $
Spread / Average Target 66,7%
EPS Revisions
Managers and Directors
Jeremy Bender President, Chief Executive Officer & Director
Charles N. York Secretary, Chief Operating & Financial Officer
Garry Allen Nicholson Chairman
Samuel Blackman Chief Medical Officer
Mike Pregih Chief Technology Operations
Sector and Competitors
1st jan.Capi. (M$)
DAY ONE BIOPHARMACEUTICALS, INC.29.02%1 599
MODERNA, INC.-28.20%70 055
IQVIA HOLDINGS INC.-22.83%40 441
LONZA GROUP AG-33.82%39 802
ALNYLAM PHARMACEUTICALS, INC.38.22%28 838
SEAGEN INC.-20.82%22 727